glp 1 risks long term Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial glp-1 long term risks long-term

The protective effects of dapagliflozin on cisplatin-induced ovarian toxicity via NRF2-HO-1 pathway and TNF-/Cas3 signaling

BYDUREON in Combination with Dapagliflozin versus BYDUREON Alone and Dapagliflozin Alone, All as Add-On to Metformin A 28-week double-blind comparator-controlled trial was conducted to compare the efficacy of BYDUREON and dapagliflozin (an SGLT2 inhibitor) to BYDUREON alone and dapagliflozin alone in patients with type 2 diabetes with inadequate glycemic control with metformin therapy (Trial 7 - NCT02229396)

Statistical Analysis Sample size calculations were performed at the beginning of this exploratory trial ( n = 40)

Time Magazine , Medicare Wont Cover GLP-1 Weight Loss Drugs (Apr 2025) ( [21] )

Broxmeyer HE, Hoggatt J, Oleary HA et al (2012) Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

The calculator shows units as a shortcut, but mL is the underlying measurement